Kazia Therapeutics Limited (KZIA)
Total Valuation
KZIA has a market cap or net worth of $14.13 million. The enterprise value is $11.85 million.
| Market Cap | 14.13M |
| Enterprise Value | 11.85M |
Important Dates
The next estimated earnings date is Friday, December 8, 2023, before market open.
| Earnings Date | Dec 8, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
KZIA has 23.63 million shares outstanding.
| Shares Outstanding | 23.63M |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.17% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 891.04 |
| Forward PS | n/a |
| PB Ratio | 1.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 747.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.42 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -135.00% and return on invested capital (ROIC) is -174.23%.
| Return on Equity (ROE) | -135.00% |
| Return on Assets (ROA) | -64.00% |
| Return on Capital (ROIC) | -174.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -179,519 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.92% in the last 52 weeks. The beta is 2.16, so KZIA's price volatility has been higher than the market average.
| Beta (1Y) | 2.16 |
| 52-Week Price Change | -1.92% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 41.64 |
| Average Volume (30 Days) | 70,326 |
Short Selling Information
| Short Interest | 5,738 |
| Short Previous Month | 113,747 |
| Short % of Shares Out | 0.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, KZIA had revenue of $15,862 and -$14.11 million in losses. Loss per share was -$0.74.
| Revenue | 15,862 |
| Gross Profit | 15,236 |
| Operating Income | -15.98M |
| Pretax Income | -13.74M |
| Net Income | -14.11M |
| EBITDA | -12.50M |
| EBIT | -13.74M |
| Loss Per Share | -$0.74 |
Balance Sheet
The company has $3.47 million in cash and $1.19 million in debt, giving a net cash position of $2.28 million or $0.10 per share.
| Cash & Cash Equivalents | 3.47M |
| Total Debt | 1.19M |
| Net Cash | 2.28M |
| Net Cash Per Share | $0.10 |
| Equity / Book Value | 7.98M |
| Book Value Per Share | 0.34 |
| Working Capital | 2.12M |
Cash Flow
| Operating Cash Flow | -10.04M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.04M |
| FCF Per Share | -$0.61 |
Margins
Gross margin is 96.05%, with operating and profit margins of -100,747.06% and -88,978.65%.
| Gross Margin | 96.05% |
| Operating Margin | -100,747.06% |
| Pretax Margin | -86,598.03% |
| Profit Margin | -88,978.65% |
| EBITDA Margin | -78,792.68% |
| EBIT Margin | -86,598.03% |
| FCF Margin | -63,294.74% |
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -99.86% |
| FCF Yield | -71.03% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.74% |
| Shareholder Yield | -72.74% |
Analyst Forecast
The average price target for KZIA is $2.00, which is 234.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 234.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 387.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 14, 2017. It was a reverse split with a ratio of 1:4.
| Last Split Date | Jul 14, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
KZIA has an Altman Z-Score of -5.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.94 |
| Piotroski F-Score | 1 |